References
- BUTT NM et al. Guideline for the investigation and management of eosinophilia. Br J Haematol 2017;176(4):553–572.
- GOTLIB J. World Health Organization-defined eosinophilic disorders: 2014 update on diagnosis, risk stratification, and management. Am J Hematol 2014;89(3):325-327.
- LERU PM. Eosinophilia and Hypereosinophilic Disorders - Update on Etiopathogeny, Classification and Clinical Approach. Rom J Intern Med 2015;53 (4):289-295.
- BONDUE A, CARPENTIER C, ROUFOSSE F. Hypereosinophilic syndrome: considerations for the cardiologist. Heart 2022;108(3):164-171.
- CAFORIO ALP, et al. Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J 2013;34(33):2636-2648
- BRACAMONTE-BARAN W, ČIHÁKOVÁ D. Cardiac Autoimmunity: Myocarditis. Adv Exp Med Biol 2017;1003: 187–221
- BRAMBATTI, M, MATASSINI V, ADLER ED, KLINGEL K, CAMICI PG, AMMIRATI E. Eosinophilic Myocarditis: Characteristics, Treatment, and Outcomes. J Am Coll Cardiol, 2017;70(19):2363-2375.
- AHKEE S, RAMIREZ J. Approach to the patient with suspected hypereosinophilic syndrome. Hematology Am Soc Hematol Educ Program 2022;1:89-92